Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Abbott Ventricular Tachycardia PAS

ClinicalTrials.gov ID: NCT05839873

Public ClinicalTrials.gov record NCT05839873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Abbott Ventricular Tachycardia Post Approval Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.

Study identification

NCT ID
NCT05839873
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
62 participants

Conditions and interventions

Eligibility (public fields only)

Age range
7 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2023 (Actual)
Primary completion
Aug 2026 (Estimated)
Completion
Nov 2026 (Estimated)
Last update posted
Oct 20, 2025

2023 – 2026

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
NCH Healthcare System Naples Florida 34102 —
St. Vincent Hospital Indianapolis Indiana 46240-0970 —
Kansas City Cardiac Arrhythmia Research Foundation Overland Park Kansas 66211 —
Massachusetts General Hospital Boston Massachusetts 02114 —
VA Medical Center Minneapolis Minneapolis Minnesota 55417 —
Carolinas Medical Center Charlotte North Carolina 28203 —
Integris Baptist Medical Center Oklahoma City Oklahoma 73112 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt Heart & Vascular Institute Nashville Tennessee 37232 —
Baylor Scott & White Heart & Vascular Hospital Dallas Texas 75226 —
University of Utah Hospital Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05839873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05839873 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →